Kymera Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $14M | 354k | 40.20 |
| 2023-12-31 | $7.8M | 307k | 25.46 |
| 2023-09-30 | $4.2M | 302k | 13.90 |
| 2023-06-30 | $6.9M | 301k | 22.99 |
| 2023-03-31 | $8.8M | 299k | 29.63 |
| 2022-12-31 | $7.4M | 298k | 24.96 |
| 2022-09-30 | $6.1M | 279k | 21.77 |
| 2022-06-30 | $5.1M | 257k | 19.69 |
| 2022-03-31 | $11M | 255k | 42.32 |
| 2021-12-31 | $16M | 249k | 63.49 |
| 2021-09-30 | $14M | 243k | 58.74 |
| 2021-06-30 | $5.0M | 104k | 48.50 |
| 2021-03-31 | $2.4M | 62k | 38.86 |
| 2020-12-31 | $3.8M | 61k | 62.00 |